Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Am J Manag Care

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    June 2021
  1. BROWN-PODGORSKI BL, Shi Y, Vest JR
    Patient need and provider referrals to diabetes self-management education.
    Am J Manag Care. 2021;27:e201-e207.
    PubMed     Abstract available


    May 2021
  2. FRIED LF, Folkerts K, Smeta B, Bowrin KD, et al
    Targeted literature review of the burden of illness in patients with chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2021;27.
    PubMed     Abstract available


  3. CAPLAN EO, Sheer R, Schmedt N, Evers T, et al
    Glomerular filtration rate change and outcomes in type 2 diabetes.
    Am J Manag Care. 2021;27.
    PubMed     Abstract available


    April 2021
  4. RAJAN M, Helmer D, Rowneki M, Fried D, et al
    Ambulatory care fragmentation and hospitalization among veterans with diabetes.
    Am J Manag Care. 2021;27:155-160.
    PubMed     Abstract available


    March 2021
  5. LANDON BE, Zaslavsky AM, Souza J, Ayanian JZ, et al
    Use of diabetes medications in traditional Medicare and Medicare Advantage.
    Am J Manag Care. 2021;27:e80-e88.
    PubMed     Abstract available


  6. LISS DT, Kang RH, Lancki N, O'Brien MJ, et al
    Costs for commercially insured adults prescribed second-line diabetes medications.
    Am J Manag Care. 2021;27:e72-e79.
    PubMed     Abstract available


  7. AHERN DK, Aberger EW, Wroblewski JP, Zheng Q, et al
    Behavior-based diabetes management: impact on care, hospitalizations, and costs.
    Am J Manag Care. 2021;27:96-102.
    PubMed     Abstract available


    December 2020
  8. SCHNEIDER D, Taddei-Allen P, Dougherty T
    The importance of patient-reported outcomes in type 2 diabetes: insight from the PIONEER program with oral semaglutide.
    Am J Manag Care. 2020;26.
    PubMed     Abstract available


  9. DOUGHERTY T, Heile M
    Type 2 diabetes in the US managed care setting: the burden of disease and rationale for an oral glucagon-like peptide-1 receptor agonist.
    Am J Manag Care. 2020;26.
    PubMed     Abstract available


  10. HEILE M, Taddei-Allen P
    The evidence for oral semaglutide in type 2 diabetes from a managed care perspective.
    Am J Manag Care. 2020;26.
    PubMed    


    November 2020
  11. CLEMENTS JM, Ragina NP, Killingsworth J, Weiss TG, et al
    Differences in spending for diabetes and multiple chronic conditions in Michigan Medicare beneficiaries.
    Am J Manag Care. 2020;26:e362-e368.
    PubMed     Abstract available


    August 2020
  12. CHEN YC, Cheng SH, Chen CC
    Keeping up with guideline recommendations: does patient volume matter in diabetes care?
    Am J Manag Care. 2020;26:e264-e271.
    PubMed     Abstract available


    June 2020
  13. RITCHIE ND, Sauder KA, Gritz RM
    Medicare Diabetes Prevention Program: where are the suppliers?
    Am J Manag Care. 2020;26:e198-e201.
    PubMed     Abstract available


    April 2020
  14. AKIROV A, Shochat T, Shimon I
    Solid-organ transplant recipients with hyperglycemia on admission face worse outcomes.
    Am J Manag Care. 2020;26:163-168.
    PubMed     Abstract available


    March 2020
  15. HUNG A, Jois B, Lugo A, Slejko JF, et al
    Cost-effectiveness of diabetes treatment sequences to inform step therapy policies.
    Am J Manag Care. 2020;26:e76-e83.
    PubMed     Abstract available


  16. MOREFIELD B, Tomai L, Slanchev V, Klemes A, et al
    Payer effects of personalized preventive care for patients with diabetes.
    Am J Manag Care. 2020;26:e70-e75.
    PubMed     Abstract available


    October 2019
  17. CONEY JM
    Addressing unmet needs in diabetic retinopathy.
    Am J Manag Care. 2019;25.
    PubMed     Abstract available


    September 2019
  18. ROSENBERG J
    As a child, diabetes was hard to accept. Now, she's living with the complications.
    Am J Manag Care. 2019;25.
    PubMed    


  19. ROSENBERG J
    For young adults with type 1 diabetes, insulin costs can mean chasing benefits, not dreams.
    Am J Manag Care. 2019;25.
    PubMed    


  20. PARK K, Jeong AE, Guenther-Gleason E, Jain SH, et al
    Impact of switching analogue insulin to human insulin in diabetes.
    Am J Manag Care. 2019;25.
    PubMed    


    July 2019
  21. DAVIS J, Lim E, Taira DA, Chen J, et al
    Healthcare network analysis of patients with diabetes and their physicians.
    Am J Manag Care. 2019;25:e192-e197.
    PubMed     Abstract available


    May 2019
  22. PAWASKAR M, Bilir SP, Kowal S, Gonzalez C, et al
    Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetes.
    Am J Manag Care. 2019;25:231-238.
    PubMed     Abstract available


    March 2019
  23. KOMPALA T, Neinstein A
    A new era: increasing continuous glucose monitoring use in type 2 diabetes.
    Am J Manag Care. 2019;25.
    PubMed    


  24. CAFFREY M, DiGrande S
    Three years after advocates report flaws, Medicare diabetes test strip bidding program nears collapse.
    Am J Manag Care. 2019;25.
    PubMed    


    February 2019
  25. WICKE FS, Glushan A, Schubert I, Koster I, et al
    Performance of the adapted Diabetes Complications Severity Index translated to ICD-10.
    Am J Manag Care. 2019;25:e45-e49.
    PubMed     Abstract available


    December 2018
  26. KIRSNER RS
    Clinical evidence for and cost-effectiveness of advanced cellular tissue products for the treatment of diabetic foot ulcers.
    Am J Manag Care. 2018;24.
    PubMed    


  27. GABBAY R
    A paradigm shift highlights the need to reduce CV risk in diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


    October 2018
  28. PANATTONI L, Chan A, Yang Y, Olson C, et al
    Nudging physicians and patients with autopend clinical decision support to improve diabetes management.
    Am J Manag Care. 2018;24:479-483.
    PubMed     Abstract available


  29. PARSONS AS, Raman V, Starr B, Zezza M, et al
    Medicare underpayment for Diabetes Prevention Program: implications for DPP suppliers.
    Am J Manag Care. 2018;24:475-478.
    PubMed     Abstract available


  30. MUNDT MP, Zakletskaia LI
    Putting the pieces together: EHR communication and diabetes patient outcomes.
    Am J Manag Care. 2018;24:462-468.
    PubMed     Abstract available


    September 2018
  31. FERNANDEZ A, Warton EM, Schillinger D, Moffet HH, et al
    Language barriers and LDL-C/SBP control among Latinos with diabetes.
    Am J Manag Care. 2018;24:405-410.
    PubMed     Abstract available


  32. WARSHAW HS
    Is it time to remodel diabetes self-management education and support?
    Am J Manag Care. 2018;24.
    PubMed    


  33. GABBAY RA
    In the era of payment reform, diabetes educators can lead the way toward value-based care.
    Am J Manag Care. 2018;24.
    PubMed    


    August 2018
  34. MCADAM-MARX C
    Economic implications with newer agents to reduce cardiovascular risk in diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  35. HUDSPETH B
    The burden of cardiovascular disease in patients with diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


    July 2018
  36. KARIMOVA K, Uhlmann L, Hammer M, Guethlin C, et al
    The development of diabetes complications in GP-centered healthcare.
    Am J Manag Care. 2018;24:322-327.
    PubMed     Abstract available


  37. ALEMAYEHU B, Speiser J, Bloudek L, Sarnes E, et al
    Costs associated with long-acting insulin analogues in patients with diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


    June 2018
  38. GANDA OP, Segal A, Blair E, Beaser R, et al
    CHAPTER 5. Clinical guideline for pharmacological management of adults with type 2 diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


  39. MUNSHI M, Blair E, Ganda OP, Gabbay RA, et al
    CHAPTER 4. Guideline for the care of the older adult with diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


  40. BROWN FM, Anderson-Haynes SE, Blair E, Serdy S, et al
    CHAPTER 3. Guideline for detection and management of diabetes in pregnancy.
    Am J Manag Care. 2018;24.
    PubMed    


  41. HAMDY O, Ganda OP, Maryniuk M, Gabbay RA, et al
    CHAPTER 2. Clinical nutrition guideline for overweight and obese adults with type 2 diabetes (T2D) or prediabetes, or those at high risk for developing T2D.
    Am J Manag Care. 2018;24.
    PubMed    


  42. HAFIDA S, Ganda OP, Gabbay RA
    CHAPTER 1. Clinical guideline for adults with diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


  43. GANDA OP, Gabbay RA
    Joslin Diabetes Center Clinical Oversight Committee.
    Am J Manag Care. 2018;24.
    PubMed    


  44. GANDA OP, Gabbay RA
    From the editors: bringing the Joslin Clinical Guidelines to the diabetes care community.
    Am J Manag Care. 2018;24.
    PubMed    


    May 2018
  45. STUART BC, Slejko JF, Rueda JD, Cooke C, et al
    Impact of formulary restrictions on medication intensification in diabetes treatment.
    Am J Manag Care. 2018;24:239-246.
    PubMed     Abstract available


    April 2018
  46. KORNELIUS E, Yang YS, Lo SC, Peng CH, et al
    Progress of diabetes severity associated with severe hypoglycemia in Taiwan.
    Am J Manag Care. 2018;24:e99-e106.
    PubMed     Abstract available


  47. WITTBRODT ET, Eudicone JM, Farahbakhshian S, McAdam-Marx C, et al
    Comparison of low-dose liraglutide use versus other GLP-1 receptor agonists in patients without type 2 diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  48. WITTBRODT ET, Eudicone JM, Bell KF, Enhoffer DM, et al
    Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  49. WITTBRODT ET, Eudicone JM, Bell KF, Enhoffer DM, et al
    Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  50. HUANG H, Bell KF, Gani R, Tugwell CW, et al
    A retrospective real-world study of dapagliflozin versus other oral antidiabetic drugs added to metformin in patients with type 2 diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


    March 2018
  51. GONZALVO JD
    Introduction to basal insulin therapy: clinical management of diabetes.
    Am J Manag Care. 2018;24.
    PubMed     Abstract available


  52. ANEESE NJ, Halalau A, Muench S, Shelden D, et al
    Impact of a pharmacist-managed diabetes clinic on quality measures.
    Am J Manag Care. 2018;24.
    PubMed    


  53. SHEERAN D
    How technology can make CMS' Diabetes Prevention Program viable.
    Am J Manag Care. 2018;24.
    PubMed    


  54. WALKER AF, Hall JM, Shenkman EA, Gurka MJ, et al
    Geographic access to endocrinologists for Florida's publicly insured children with diabetes.
    Am J Manag Care. 2018;24.
    PubMed    


    February 2018
  55. AGIRO A, Xie Y, Bowman K, DeVries A, et al
    Leveraging benefit design for better diabetes self-management and A1C control.
    Am J Manag Care. 2018;24:e30-e36.
    PubMed     Abstract available


    January 2018
  56. GRAETZ I, Huang J, Brand RJ, Hsu J, et al
    Bridging the digital divide: mobile access to personal health records among patients with diabetes.
    Am J Manag Care. 2018;24:43-48.
    PubMed     Abstract available


    December 2017
  57. GABBAY RA
    For those with diabetes and CV risk, personalized care matters.
    Am J Manag Care. 2017;23.
    PubMed    


    November 2017
  58. MIN L, Cigolle CT, Bernstein SJ, Ward K, et al
    Diabetes care improvement in pharmacist- versus nurse-supported patient-centered medical homes.
    Am J Manag Care. 2017;23:e374-e381.
    PubMed     Abstract available


    October 2017
  59. JONES C, Mohlman MK, Jorgenson D, Finison K, et al
    Statewide data infrastructure supports population health management: diabetes case study.
    Am J Manag Care. 2017;23:e331-e339.
    PubMed     Abstract available


    August 2017
  60. MORELLO CM
    Overview of the cardiovascular benefit with diabetic agents and novel combination products for type 2 diabetes.
    Am J Manag Care. 2017;23.
    PubMed     Abstract available


  61. MORELLO CM, Hirsch JD
    Strategies for addressing the cost of nonadherence in diabetes.
    Am J Manag Care. 2017;23.
    PubMed     Abstract available


  62. HIRSCH JD, Morello CM
    Economic impact of and treatment options for type 2 diabetes.
    Am J Manag Care. 2017;23.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: